News for hackers. Stuff that matters.
Re:Alzheimer’s Drug Sharply Slowed Cognitive Decline by jonlucc on Friday March 20, 2015 @09:21PM (#9241540)
I'm pretty sure if they add efficacy endpoints to Phase I, it becomes a Phase I/Phase II and the efficacy is for Phase II. The other problem with efficacy in Phase I is that alzheimer's efficacy is not measured over such short time frames.

There are no comments on this comment yet.